Pain Wizard Topical Pain Relief Recalled for Out-of-Specification Active Ingredient
ARG Laboratories recalls Pain Wizard topical pain relief nationwide due to out-of-specification active ingredient and violative-grade propylene glycol used in manufacturing. No illnesses reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving out-of-specification active ingredient and manufacturing quality-control defects with violative-grade propylene glycol. No reported illnesses or hospitalizations, limiting severity to High rather than Severe.
Plain-English summary
ARG Laboratories, Inc. is recalling Pain Wizard, a topical pain relief product containing 3% camphor and 3% menthol, distributed nationwide in a 16 fluid ounce bottle with pump (Lot 18723C3, expiration 06/30/2025).
The recall is due to out-of-specification levels of the active ingredient and the use of a violative grade of propylene glycol during manufacturing. These quality control failures could affect product safety and efficacy.
No illnesses or injuries have been reported. Consumers who have purchased this product should stop using it and contact Pain Wizard LLC at PO Box 1099, Johnstown, CO 80534, or visit www.painwizard.com for a refund or replacement.
The recalled product
- Product
- Pain Wizard, Natural Relief for Muscular & Arthritic Pain, (Camphor 3%, Menthol 3%), Enriched with Capsaicin, Camphor, Menthol & MSM, Bottle with pump, NET WT 16 fluid oz / 473.17 ml, Made in USA, www.painwizard.com Pain Wizard LLC.PO Box 1099, Johnstown, CO 80534, UPC 8 63865
- Manufacturer
- ARG Laboratories, Inc.
- Category
- Drug — Topical Pain Relief
- Hazard
- out-of-specification
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 18723C3
- Exp 06/30/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27